السوق العالمية للتلقيح الاصطناعي – اتجاهات الصناعة والتوقعات حتى عام 2029

تحليل السوق والحجم

في السنوات الأخيرة، من المتوقع أن ينمو سوق التلقيح الاصطناعي بسرعة خلال الفترة المتوقعة. وفقًا لدراسة نُشرت في مجلة PLOS Medicine في عام 2012، لم يتمكن حوالي 48.5 مليون زوجين في جميع أنحاء العالم من إنجاب طفل في عام 2010. غالبًا ما تقدم شركات السوق مجموعات الاستخدام المنزلي، مثل مجموعات التبويض ومجموعات الكشف عن الحمل وأجهزة التلقيح. التلقيح الاصطناعي هو إجراء طبي يتضمن حقن الحيوانات المنوية عمدًا في رحم الأنثى دون استخدام الجماع. النوع الأكثر استخدامًا من التلقيح الاصطناعي هو التلقيح داخل الرحم (IUI). يعد انتشار العقم المتزايد عنصرًا رئيسيًا يدفع سوق التلقيح الاصطناعي إلى الأمام.

تحلل شركة Data Bridge Market Research أن سوق التلقيح الاصطناعي قُدرت بقيمة 2,198.75 مليون دولار أمريكي في عام 2021 ومن المتوقع أن تصل إلى 4099.98 مليون دولار أمريكي بحلول عام 2029، مسجلة معدل نمو سنوي مركب بنسبة 8.10٪ خلال الفترة المتوقعة من 2022 إلى 2029. يتضمن تقرير السوق الذي أعده فريق Data Bridge Market Research تحليلًا متعمقًا من الخبراء، وعلم الأوبئة لدى المرضى، وتحليل خطوط الأنابيب، وتحليل الأسعار، والإطار التنظيمي.

تعريف السوق

 التلقيح الاصطناعي هو شكل من أشكال التكاثر بمساعدة الغير حيث يتم حقن قناتي فالوب أو عنق الرحم أو الرحم لدى الأنثى بالحيوانات المنوية التي لا تزال حية. يتم ذلك من خلال إجراءات التلقيح الاصطناعي السريع وغير المؤلم (AIH) أو التلقيح الاصطناعي بالسائل المنوي للمتبرع (AID). يتم استخدام التلقيح الاصطناعي الآن بشكل عام في تربية الحيوانات لتحسين النجاح الإنجابي والحفاظ على الأنواع النادرة والمهددة بالانقراض. كما أنه يساعد على تجنب انتشار الأمراض والعقم في الحيوانات بسبب مشاكل الأعضاء التناسلية.

نطاق التقرير وتقسيم السوق

Artificial Insemination Market Dynamics

Drivers

• Increasing incidence of infertility

Infertility affects nearly 20 million women, according to the National Women's Health Resource Center. Total fertility is anticipated to decline from 2.43 to 2.39 (children per woman) between 2020 and 2030, according to the 2017 United Nations World Population Prospects report. The growing incidences of infertility among the world's population is propelling the artificial insemination market forward.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of artificial insemination market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, the rising preference of modern women on Planned Parenthood because of uninterrupted full time professional career will influence the growth of artificial insemination market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the artificial insemination market. Also, changing lifestyle of people and rising awareness among individuals about alternative reproductive treatments are the major market drivers that will further escalate the growth of artificial insemination market.

Opportunities

• Increase in strategic collaborations and new product launches      

Moreover, the market's growth is fueled by an increase in the number of new product launch and strategic collaboration of leading market players. This will provide beneficial opportunities for the artificial insemination market growth.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the artificial insemination market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with artificial insemination will obstruct the growth rate of market. The dearth of skilled professionals and lack of awareness will challenge the artificial insemination market. Additionally, impact of COVID-19 on supply chain and strict regulatory issues will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This artificial insemination market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial insemination market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Artificial Insemination Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The artificial insemination market was hampered by the supply chain slowness.

Global Artificial Insemination Market Scope

The artificial insemination market is segmented on the basis of type, product type, source type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Product Type

• Insemination Kits
• Home Conception Devices
• Accessories

Source Type

• AIH-Husband
• AID-Donor

End- User

• Hospitals
• Fertility Clinics
• Clinics
• Others

Artificial Insemination Market Regional Analysis/Insights

The artificial insemination market is analysed and market size insights and trends are provided by country, type, product type, source type and end-user as referenced above.

The countries covered in the artificial insemination market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the artificial insemination market because of the well-established healthcare infrastructure and technological advancement in this region. Additionally, presence of major key players and favourable rules and regulations will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to rising prevalence of infertility among the populace and development of healthcare sector this region. Also, less stringent regulations will flourish the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The artificial insemination market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for artificial insemination market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the artificial insemination market. The data is available for historic period 2010-2020.

Competitive Landscape and Artificial Insemination Market Share Analysis

يقدم المشهد التنافسي لسوق التلقيح الاصطناعي تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق التلقيح الاصطناعي.

بعض اللاعبين الرئيسيين العاملين في سوق التلقيح الاصطناعي هم:

• كونسيفكس، المحدودة (الولايات المتحدة)
• ملاك الفخر (المملكة المتحدة)
• فوجي فيلم إيرفين ساينتيفيك (الولايات المتحدة)
• الحلول التكنولوجية المتقدمة (الولايات المتحدة)
• شركة رينوفوم لصحة المرأة، ذ.م.م (الولايات المتحدة)
• مركز تندر نيدز للخصوبة (الولايات المتحدة)
• شركة بيوجينيكس (الولايات المتحدة)
• شركة لابوتكت المحدودة (ألمانيا)
• هاملتون ثورن، المحدودة (الولايات المتحدة)
• شركة نيكون إنسترومنتس (الولايات المتحدة)
• شركة زاندر العلمية (الولايات المتحدة)
• شركة شورلايف المحدودة (سنغافورة)
• جينيا المحدودة (أستراليا)
• شركة كيتازاتو (اليابان)
• شركة روكيت ميديكال المحدودة (المملكة المتحدة)
• فيترولايف (السويد)

SKU-68170